Debt-to-equity of Dare Bioscience, Inc. from 31 Mar 2018 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Dare Bioscience, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2018 to 30 Sep 2025.
Dare Bioscience, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -432%, a 29% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Dare Bioscience, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	-432%	+179%	+29%	30 Sep 2025
Q2 2025	-341%	+289%	+46%	30 Jun 2025
Q1 2025	-673%	-180%	-37%	31 Mar 2025
Q4 2024	-585%	+1480%	+72%	31 Dec 2024
Q3 2024	-611%	-1617%	-161%	30 Sep 2024
Q2 2024	-630%	-902%	-331%	30 Jun 2024
Q1 2024	-492%	-625%	-469%	31 Mar 2024
Q4 2023	-2065%	-2157%	-2341%	31 Dec 2023
Q3 2023	1006%	+945%	+1569%	30 Sep 2023
Q2 2023	272%	+220%	+418%	30 Jun 2023
Q1 2023	133%	+79%	+145%	31 Mar 2023
Q4 2022	92%	+33%	+56%	31 Dec 2022
Q3 2022	60%	-35%	-37%	30 Sep 2022
Q2 2022	52%	-327%	-86%	30 Jun 2022
Q1 2022	54%	-3170%	-98%	31 Mar 2022
Q4 2021	59%	-3282%	-98%	31 Dec 2021
Q3 2021	96%	-1118%	-92%	30 Sep 2021
Q2 2021	379%	-42%	-10%	30 Jun 2021
Q1 2021	3224%	+3051%	+1763%	31 Mar 2021
Q4 2020	3342%	+3229%	+2873%	31 Dec 2020
Q3 2020	1213%	+1175%	+3104%	30 Sep 2020
Q2 2020	421%	+398%	+1751%	30 Jun 2020
Q1 2020	173%	+158%	+1060%	31 Mar 2020
Q4 2019	112%	+102%	+1036%	31 Dec 2019
Q3 2019	38%	+30%	+353%	30 Sep 2019
Q2 2019	23%	+17%	+274%	30 Jun 2019
Q1 2019	15%	+6.7%	+82%	31 Mar 2019
Q4 2018	9.9%			31 Dec 2018
Q3 2018	8.4%			30 Sep 2018
Q2 2018	6.1%			30 Jun 2018
Q1 2018	8.2%			31 Mar 2018

* An asterisk sign (*) next to the value indicates that the value is likely invalid.